Walter Stummer

Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial

Walter Stummer, Uwe Pichlmeier, Thomas R. Meinel et al. · The Lancet Oncology · 2006 · 3.3K citations

Neuro-oncology, Surgical Oncology, Oncologic Imaging +11

EXTENT OF RESECTION AND SURVIVAL IN GLIOBLASTOMA MULTIFORME

Walter Stummer, H. J. Reulen, Thomas R. Meinel et al. · Neurosurgery · 2008 · 1K citations

Fluorescence-guided resection of glioblastoma multiforme utilizing 5-ALA-induced porphyrins: a prospective study in 52 consecutive patients

Walter Stummer, Alexander Novotny, Herbert Stepp et al. · Journal of neurosurgery · 2000 · 863 citations

Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial

Ulrich Herrlinger, Theophilos Tzaridis, Frederic Mack et al. · The Lancet · 2019 · 556 citations · Full text

Hematological Malignancy, Neuro-oncology, Treatment Strategies +13

Influence of cranioplasty on postural blood flow regulation, cerebrovascular reserve capacity, and cerebral glucose metabolism

Peter Winkler, Walter Stummer, R. Linke et al. · Journal of neurosurgery · 2000 · 337 citations